User menu

Medicinal chemistry endeavors around the phytocannabinoids.

Bibliographic reference Stern, Eric ; Lambert, Didier. Medicinal chemistry endeavors around the phytocannabinoids.. In: Chemistry & biodiversity, Vol. 4, no. 8, p. 1707-28 (2007)
Permanent URL http://hdl.handle.net/2078.1/11076
  1. ElSohly, Life Sci., 78, 539 (2005)
  2. Mechoulam, Chem. Phys. Lipids, 108, 1 (2000)
  3. Mechoulam, Curr. Pharm. Des., 6, 1313 (2000)
  4. Adams, J. Am. Chem. Soc., 62, 196 (1940)
  5. Adams, J. Am. Chem. Soc., 62, 2204 (1940)
  6. Mechoulam, Tetrahedron, 19, 2073 (1963)
  7. Gaoni, J. Am. Chem. Soc., 86, 1646 (1964)
  8. Mechoulam, Tetrahedron Lett., 8, 1109 (1967)
  9. Howlett, Life Sci., 35, 1803 (1984)
  10. Howlett, Mol. Pharmacol., 26, 532 (1984)
  11. Howlett, Mol. Pharmacol., 29, 307 (1986)
  12. Matsuda, Nature, 346, 561 (1990)
  13. Howlett, Pharmacol. Rev., 54, 161 (2002)
  14. Walton, J. Pharmacol. Exp. Ther., 62, 239 (1938)
  15. Edery, Ann. N.Y. Acad. Sci., 191, 40 (1971)
  16. Martin, Pharmacol. Rev., 38, 45 (1986)
  17. Razdan, Pharmacol. Rev., 38, 75 (1986)
  18. Howlett, Mol. Pharmacol., 27, 429 (1985)
  19. Devane, Mol. Pharmacol., 34, 605 (1988)
  20. Herkenham, Proc. Natl. Acad. Sci. U.S.A., 87, 1932 (1990)
  21. Herkenham, J. Neurosci., 11, 563 (1991)
  22. Pertwee, Curr. Med. Chem., 6, 635 (1999)
  23. Devane, J. Med. Chem., 35, 2065 (1992)
  24. Rhee, J. Med. Chem., 40, 3228 (1997)
  25. Kuster, J. Pharmacol. Exp. Ther., 264, 1352 (1993)
  26. Rinaldi-Carmona, Life Sci., 58, 1239 (1996)
  27. Stern, J. Med. Chem., 49, 70 (2006)
  28. Seltzman, J. Labelled Compd. Radiopharm., 48, 589 (2005)
  29. Gonsiorek, J. Biol. Chem., 281, 28143 (2006)
  30. Munro, Nature, 365, 61 (1993)
  31. Sickle, Science, 310, 329 (2005)
  32. Sawzdargo, Brain Res. Mol. Brain Res., 64, 193 (1999)
  33. Overton, Cell Metab., 3, 167 (2006)
  34. Petitet, Chem. Biol. Drug Des., 67, 252 (2006)
  35. Baker, Trends Pharmacol. Sci., 27, 1 (2006)
  36. Burkey, Eur. J. Pharmacol., 23 (1997)
  37. Burkey, Eur. J. Pharmacol., 336, 295 (1997)
  38. Bayewitch, J. Biol. Chem., 271, 9902 (1996)
  39. Sim, J. Neurosci., 16, 8057 (1996)
  40. Kearn, J. Neurochem., 72, 2379 (1999)
  41. Breivogel, J. Pharmacol. Exp. Ther., 295, 328 (2000)
  42. Govaerts, Eur. J. Pharm. Sci., 23, 233 (2004)
  43. Lam, Br. J. Anaesth., 94, 649 (2005)
  44. Gérard C M, Mollereau C, Vassart G, Parmentier M, Molecular cloning of a human cannabinoid receptor which is also expressed in testis, 10.1042/bj2790129
  45. Glass, Mol. Pharmacol., 56, 1362 (1999)
  46. Lim Chang-Jin, Sa Jae-Hoon, Fuchs James A., Identification of a third thioredoxin gene from Corynebacterium nephridii, 10.1016/0167-4781(96)00038-3
  47. Bayewitch, FEBS Lett., 375, 143 (1995)
  48. Zias, Nature, 363, 215 (1993)
  49. Martin, Life Sci., 29, 565 (1981)
  50. Khanolkar, Chem. Phys. Lipids, 108, 37 (2000)
  51. Martin, J. Pharmacol. Exp. Ther., 290, 1065 (1999)
  52. Thomas, Br. J. Pharmacol., 146, 917 (2005)
  53. Jr., J. Am. Chem. Soc., 70, 664 (1948)
  54. Aaron, J. Org. Chem., 33, 684 (1968)
  55. Edery, Arzneim.-Forsch., 22, 1995 (1972)
  56. Petrzilka, Helv. Chim. Acta, 52, 1102 (1969)
  57. Huffman, Bioorg. Med. Chem. Lett., 7, 2799 (1997)
  58. Huffman, Tetrahedron, 53, 1557 (1997)
  59. Palmer, Chem. Phys. Lipids, 121, 3 (2002)
  60. Martin, Eur. J. Pharmacol., 435, 35 (2002)
  61. Papahatjis, J. Med. Chem., 41, 1195 (1998)
  62. Ryan, Life Sci., 56, 2013 (1995)
  63. Pertwee, Eur. J. Pharmacol., 315, 195 (1996)
  64. Griffin, Br. J. Pharmacol., 126, 1575 (1999)
  65. Khanolkar, Bioorg. Med. Chem. Lett., 9, 2119 (1999)
  66. Charalambous, Pharmacol. Biochem. Behav., 40, 509 (1991)
  67. Martin, Pharmacol. Biochem. Behav., 46, 295 (1993)
  68. Nikas, Am. Assoc. Pharm. Sci. J., 6 (2004)
  69. Charalambous, Pharmacol. Biochem. Behav., 40, 503 (1991)
  70. Martin, J. Pharmacol. Exp. Ther., 318, 1230 (2006)
  71. Papahatjis, Chem. Lett., 3, 192 (2001)
  72. Papahatjis, Bioorg. Med. Chem. Lett., 12, 3583 (2002)
  73. Papahatjis, J. Med. Chem., 46, 3221 (2003)
  74. Nadipuram, Bioorg. Med. Chem. Lett., 11, 3121 (2003)
  75. Krishnamurthy, Bioorg. Med. Chem. Lett., 13, 3487 (2003)
  76. Papahatjis, Bioorg. Med. Chem. Lett., 16, 1616 (2006)
  77. Lu, J. Med. Chem., 48, 4576 (2005)
  78. Goanvic, J. Org. Chem., 71, 7800 (2006)
  79. , W.O. Pat. 01/28329, 2001.
  80. Huffman, Bioorg. Med. Chem., 8, 439 (2000)
  81. Mechoulam, Chem. Biodiv., 4, 1678 (2007)
  82. Razdan, J. Am. Chem. Soc, 96, 5860 (1974)
  83. Offertaler, Mol. Pharmacol., 63, 699 (2003)
  84. Wagner, J. Cardiovasc. Pharmacol., 46, 348 (2005)
  85. Thomas, Eur. J. Pharmacol., 487, 213 (2004)
  86. Thomas, Br. J. Pharmacol., 150, 613 (2007)
  87. Ben-Shabat, J. Med. Chem., 49, 1113 (2006)
  88. Wilson, J. Med. Chem., 19, 1165 (1976)
  89. Melvin, J. Med. Chem., 27, 67 (1984)
  90. Melvin, Mol. Pharmacol., 44, 1008 (1993)
  91. Griffin, J. Pharmacol. Exp. Ther., 285, 553 (1998)
  92. Gareau, Bioorg. Med. Chem. Lett., 6, 189 (1996)
  93. Grotenhermen, Cannabinoids, 1, 10 (2006)
  94. Davis, Support Care Cancer, 15, 63 (2007)
  95. Hirst R. A., Lambert D. G., Notcutt W. G., Pharmacology and potential therapeutic uses of cannabis, 10.1093/bja/81.1.77
  96. Lagu, Drug Des. Discov., 12, 179 (1995)
  97. Mechoulam, Experientia, 44, 762 (1988)
  98. Järbe, Eur. J. Pharmacol., 156, 361 (1988)
  99. Little, Pharmacol. Biochem. Behav., 32, 661 (1989)
  100. Govaerts, Eur. J. Pharmacol., 495, 43 (2004)
  101. Bosier, J. Neurochem., 10 (2007)
  102. Muccioli, J. Med. Chem., 48, 7486 (2005)
  103. Mechoulam, Pharmacol. Biochem. Behav., 40, 461 (1991)
  104. Yan, J. Med. Chem., 37, 2619 (1994)
  105. Picone, Mol. Pharmacol., 68, 1623 (2005)
  106. Titishov, Pharmacology, 39, 337 (1989)
  107. Järbe, J. Pharmacol. Exp. Ther., 250, 1000 (1989)
  108. Felder, Mol. Pharmacol., 42, 838 (1992)
  109. Erratum, Mol. Pharmacol., 46, 397 (1994)
  110. Shohami, Brain Res., 674, 55 (1995)
  111. Bar-Joseph, Mol. Chem. Neuropathol., 23, 125 (1994)
  112. Belayev, Mol. Chem. Neuropathol., 25, 19 (1995)
  113. Filbert, Ann. N.Y. Acad. Sci., 890, 505 (1999)
  114. Feigenbaum, Proc. Natl. Acad. Sci. U.S.A., 86, 9584 (1989)
  115. Zeltser, Pain, 47, 95 (1991)
  116. Nadler, Brain Res., 622, 79 (1993)
  117. Nadler, Neurosci. Lett., 162, 43 (1993)
  118. Eshhar, Eur. J. Pharmacol., 283, 19 (1995)
  119. Shohami, J. Neuroimmunol., 72, 169 (1997)
  120. Juttler, Neuropharmacology, 47, 580 (2004)
  121. Gallily, J. Pharmacol. Exp. Ther., 283, 918 (1997)
  122. Mechoulam, Trends Mol. Med., 8, 58 (2002)
  123. Int., Drugs Res. Dev., 4, 185 (2003)
  124. Pop, Curr. Opin. Invest. Drugs, 1, 494 (2000)
  125. Brewster, Int. J. Clin. Pharmacol. Ther., 35, 361 (1997)
  126. Pop, Pharm. Res., 13, 62 (1996)
  127. Pop, Pharm. Res., 13, 469 (1996)
  128. Naveh, Graefes Arch. Clin. Exp. Ophthalmol., 238, 334 (2000)
  129. Beilin, J. Ocul. Pharmacol. Ther., 16, 217 (2000)
  130. Knoller, Crit. Care Med., 30, 548 (2002)
  131. Maas, Lancet Neurol., 5, 38 (2006)
  132. Bisogno, Br. J. Pharmacol., 134, 845 (2001)
  133. JACOB JOSEPH J., RAMABADRAN KRISHNASWAMI, CAMPOS-MEDEIROS MARY, A Pharmacological Analysis of Levonantradol Antinociception in Mice, 10.1002/j.1552-4604.1981.tb02611.x
  134. JAIN ADESH K., RYAN JEROME R., McMAHON F. GILBERT, SMITH GLADYS, Evaluation of Intramuscular Levonantradol and Placebo in Acute Postoperative Pain, 10.1002/j.1552-4604.1981.tb02610.x
  135. YAKSH TONY L., The Antinociceptive Effects of Intrathecally Administered Levonantradol and Desacetyllevonantradol in the Rat, 10.1002/j.1552-4604.1981.tb02612.x
  136. JOHNSON M. R., MELVIN L. S., ALTHUIS T. H., BINDRA J. S., HARBERT C. A., MILNE G. M., WEISSMAN A., Selective and Potent Analgetics Derived from Cannabinoids, 10.1002/j.1552-4604.1981.tb02605.x
  137. Campbell, Br. Med. J., 323, 13 (2001)
  138. Koe, Eur. J. Pharmacol., 70, 231 (1981)
  139. Milne, NIDA Res. Monogr., 27, 84 (1979)
  140. Darmani, Neuropsychopharmacology, 24, 198 (2001)
  141. CRONIN CAROL M., SALLAN STEPHEN E., GELBER RICHARD, LUCAS VIRGIL S., LASZLO JOHN, Antiemetic Effect of Intramuscular Levonantradol in Patients Receiving Anticancer Chemotherapy, 10.1002/j.1552-4604.1981.tb02572.x
  142. Tramer, Br. Med. J., 323, 16 (2001)
  143. EHLERS C. L., HENRIKSEN S. J., BLOOM F. E., Levonantradol Potentiates the Anticonvulsant Effects of Diazepam and Valproic Acid in the Kindling Model of Epilepsy, 10.1002/j.1552-4604.1981.tb02620.x
  144. KOE B. KENNETH, WEISSMAN ALBERT, Facilitation of Benzodiazepine Binding by Levonantradol, 10.1002/j.1552-4604.1981.tb02619.x
  145. LAL HARBANS, BENNETT DEBRA A., SHEARMAN GARY T., McCARTEN MICHAEL D., MURPHY RUSSELL, ANGEJA ANTONIO, Effectiveness of Nantradol in Blocking Narcotic Withdrawal Signs Through Nonnarcotic Mechanisms, 10.1002/j.1552-4604.1981.tb02615.x
  146. GILBERT PAUL E., A Comparison of THC, Nantradol, Nabilone, and Morphine in the Chronic Spinal Dog, 10.1002/j.1552-4604.1981.tb02609.x
  147. Lucraft, Clin. Radiol., 33, 621 (1982)
  148. DIASIO ROBERT B., ETTINGER DAVID S., SATTERWHITE BARBARA E., Oral Levonantradol in the Treatment of Chemotherapy-Induced Emesis: Preliminary Observations, 10.1002/j.1552-4604.1981.tb02579.x
  149. LASZLO JOHN, LUCAS VIRGIL S., HANSON DEAN C., CRONIN CAROL M., SALLAN STEPHEN E., Levonantradol for Chemotherapy-Induced Emesis: Phase I-II Oral Administration, 10.1002/j.1552-4604.1981.tb02573.x
  150. Howlett, J. Neurochem., 74, 2174 (2000)
  151. Kogan, J. Med. Chem., 47, 3800 (2004)
  152. Kogan, Mol. Pharmacol., 70, 51 (2006)
  153. Kogan, Mol. Cancer Ther., 6, 173 (2007)
  154. Kogan, J. Pharmacol. Exp. Ther. (2007)